Latest Regulatory Approval News

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.

Latitude Group Holdings Limited has revised its distribution on Capital Notes from AUD 1.6136 to AUD 2.3052, reflecting a shift to a 0% franked component and the introduction of conduit foreign income.

Echelon Resources has agreed to acquire full ownership and operatorship of the EP145 exploration permit in the Northern Territory’s Amadeus Basin, aiming to unlock a discovered gas resource with modern technology.

Peninsula Energy has resumed uranium production at its Lance Project in Wyoming, capturing 1,100 pounds of uranium in late December 2024, while securing key regulatory approvals to expand mining operations.

Amcor plc and Berry Global Group, Inc. have entered into a definitive merger agreement for an all-stock transaction valued at approximately $9.9 billion. The combined entity aims to leverage significant synergies and enhanced market reach, pending shareholder and regulatory approvals.

Element 25 has obtained key regulatory approval from WA's DEMIRS for its Butcherbird Expansion Project, paving the way for a twelve-year production run at 1.1 million tonnes per annum of manganese concentrate. The final hurdle remains the Works Approval, expected imminently.

Lakes Blue Energy has completed the sale of its 49% stake in PEP 169, receiving $6.5 million and securing a 4% royalty on future production. The company now shifts focus to advancing drilling at its Wombat and Trifon/Gangell fields in the Gippsland Basin.

Advance Metals Limited has entered binding agreements to acquire significant interests in high-grade gold projects in Victoria, Australia, and a major silver project in Durango, Mexico, expanding its precious metals portfolio amid record metal prices.

EBR Systems has announced a rescheduling of the FDA Pre-Approval Inspection for its wireless cardiac pacing device to January 14, 2025, while maintaining its regulatory approval timeline for Q1 2025 and a commercial launch later in the year.